Intellectual Property India Publishes Patent Application for 'A Vaccine Composition Of Cells Expressing A Lentiviral Vector And Methods Of Using' Filed by Meridian Therapeutics, Inc.

MUMBAI, India, March 15 -- Intellectual Property India has published a patent application (202437102407 A) filed by Meridian Therapeutics, Inc., Draper, U.S.A., on Dec. 24, 2024, for 'a vaccine composition of cells expressing a lentiviral vector and methods of using.'

Inventor(s) include Noonan, Kimberly, A.; and Borrello, Ivan, R.

The application for the patent was published on March 14, under issue no. 11/2025.

According to the abstract released by the Intellectual Property India: "A vector construct is described that is a lentiviral construct including DNA encoding for GM- CSF A vaccine composition is also described that is includes K562 cells transfected with this vector construct, and also possibly including the U266 and H929. Metho...